Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Ugo

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 27, 2014
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS): study design and methodsClaudio Moretti, Erika Cavallero, Fabrizio D'Ascenzo, et al.
The American Journal of Cardiology|January 30, 2017
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study)Fabrizio D'Ascenzo, Alaide Chieffo, Enrico Cerrato, et al.
Frontiers in Cardiovascular Medicine|August 14, 2024
Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registryMichela Bonanni, Marco Frazzetto, Annalisa Nardone, et al.
International Journal of Cardiology|February 1, 2016
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study)Simone Biscaglia, Fabrizio Ugo, Alfonso Ielasi, et al.
International Journal of Cardiology|October 11, 2017
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-studyHiroyoshi Kawamoto, Alaide Chieffo, Fabrizio D'Ascenzo, et al.
Journal of Critical Care|March 28, 2022
Prognostic implications of pulmonary artery catheter monitoring in patients with cardiogenic shock: A systematic review and meta-analysis of observational studiesMaurizio Bertaina, Alessandro Galluzzo, Xavier Rossello, et al.
The American Journal of Cardiology|May 11, 2017
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting StentsSebastiano Gili, Fabrizio D'Ascenzo, Roberto Di Summa, et al.
European Heart Journal. Acute Cardiovascular Care|January 20, 2018
Diagnostic accuracy of functional, imaging and biochemical tests for patients presenting with chest pain to the emergency department: A systematic review and meta-analysisMario Iannaccone, Sebastiano Gili, Ovidio De Filippo, et al.
Open Heart|September 18, 2025
Phenomapping-derived selection of fractional flow reserve or optical coherence tomography to personalise percutaneous coronary interventionFabrizio D'Ascenzo, Isabella Caranzano, Ovidio De Filippo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2019
Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study)Enrico Cerrato, Umberto Barbero, Giorgio Quadri, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 27, 2014
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS): study design and methodsClaudio Moretti, Erika Cavallero, Fabrizio D'Ascenzo, et al.
The American Journal of Cardiology|January 30, 2017
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study)Fabrizio D'Ascenzo, Alaide Chieffo, Enrico Cerrato, et al.
Frontiers in Cardiovascular Medicine|August 14, 2024
Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registryMichela Bonanni, Marco Frazzetto, Annalisa Nardone, et al.
International Journal of Cardiology|February 1, 2016
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study)Simone Biscaglia, Fabrizio Ugo, Alfonso Ielasi, et al.
International Journal of Cardiology|October 11, 2017
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-studyHiroyoshi Kawamoto, Alaide Chieffo, Fabrizio D'Ascenzo, et al.
Journal of Critical Care|March 28, 2022
Prognostic implications of pulmonary artery catheter monitoring in patients with cardiogenic shock: A systematic review and meta-analysis of observational studiesMaurizio Bertaina, Alessandro Galluzzo, Xavier Rossello, et al.
The American Journal of Cardiology|May 11, 2017
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting StentsSebastiano Gili, Fabrizio D'Ascenzo, Roberto Di Summa, et al.
European Heart Journal. Acute Cardiovascular Care|January 20, 2018
Diagnostic accuracy of functional, imaging and biochemical tests for patients presenting with chest pain to the emergency department: A systematic review and meta-analysisMario Iannaccone, Sebastiano Gili, Ovidio De Filippo, et al.
Open Heart|September 18, 2025
Phenomapping-derived selection of fractional flow reserve or optical coherence tomography to personalise percutaneous coronary interventionFabrizio D'Ascenzo, Isabella Caranzano, Ovidio De Filippo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2019
Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study)Enrico Cerrato, Umberto Barbero, Giorgio Quadri, et al.
Pageof 9